Yabao Pharmaceutical Group Co Ltd
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 a… Read more
Yabao Pharmaceutical Group Co Ltd (600351) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.047x
Based on the latest financial reports, Yabao Pharmaceutical Group Co Ltd (600351) has a cash flow conversion efficiency ratio of 0.047x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥129.49 Million) by net assets (CN¥2.76 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yabao Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Yabao Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Yabao Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yabao Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tianshui Zhongxing Bio-technology Co Ltd
SHE:002772
|
0.042x |
|
Ingentec Corporation
TWO:4768
|
N/A |
|
Norbit ASA
OL:NORBT
|
-0.002x |
|
GZ Port
SHG:601228
|
0.010x |
|
KATITAS CO., Ltd.
PINK:KTITF
|
N/A |
|
INVEX Controladora S.A.B. de C.V
MX:INVEXA
|
0.059x |
|
Henan Thinker Automation
SHG:603508
|
0.029x |
|
Vijaya Diagnostic Centre Limited
NSE:VIJAYA
|
0.034x |
Annual Cash Flow Conversion Efficiency for Yabao Pharmaceutical Group Co Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.89 Billion | CN¥471.69 Million | 0.163x | -1.98% |
| 2023-12-31 | CN¥2.99 Billion | CN¥497.55 Million | 0.166x | +8.54% |
| 2022-12-31 | CN¥3.01 Billion | CN¥460.46 Million | 0.153x | +3.74% |
| 2021-12-31 | CN¥2.96 Billion | CN¥437.50 Million | 0.148x | +9.21% |
| 2020-12-31 | CN¥2.82 Billion | CN¥380.96 Million | 0.135x | -13.38% |
| 2019-12-31 | CN¥2.72 Billion | CN¥425.17 Million | 0.156x | +10.21% |
| 2018-12-31 | CN¥3.01 Billion | CN¥426.60 Million | 0.142x | +155.17% |
| 2017-12-31 | CN¥2.91 Billion | CN¥161.73 Million | 0.055x | -2.85% |
| 2016-12-31 | CN¥2.73 Billion | CN¥155.95 Million | 0.057x | +6.62% |
| 2015-12-31 | CN¥2.68 Billion | CN¥143.47 Million | 0.054x | -45.42% |
| 2014-12-31 | CN¥1.82 Billion | CN¥178.63 Million | 0.098x | +193.10% |
| 2013-12-31 | CN¥1.70 Billion | CN¥56.80 Million | 0.033x | +155.92% |
| 2012-12-31 | CN¥1.62 Billion | CN¥-96.73 Million | -0.060x | -270.37% |
| 2011-12-31 | CN¥1.16 Billion | CN¥40.73 Million | 0.035x | +89.80% |
| 2010-12-31 | CN¥1.00 Billion | CN¥18.57 Million | 0.019x | -95.48% |
| 2009-12-31 | CN¥899.55 Million | CN¥368.56 Million | 0.410x | +230.61% |
| 2008-12-31 | CN¥830.32 Million | CN¥102.90 Million | 0.124x | -55.43% |
| 2007-12-31 | CN¥380.08 Million | CN¥105.69 Million | 0.278x | +702.54% |
| 2006-12-31 | CN¥334.54 Million | CN¥11.59 Million | 0.035x | -53.49% |
| 2005-12-31 | CN¥354.37 Million | CN¥26.40 Million | 0.074x | -68.41% |
| 2004-12-31 | CN¥338.16 Million | CN¥79.73 Million | 0.236x | +879.94% |
| 2003-12-31 | CN¥318.26 Million | CN¥-9.62 Million | -0.030x | -134.57% |
| 2002-12-31 | CN¥277.81 Million | CN¥24.29 Million | 0.087x | -65.96% |
| 2001-12-31 | CN¥91.84 Million | CN¥23.59 Million | 0.257x | -- |